Clinical Trial Update: Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Eltrombopag (eltrombopag)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Severe Aplastic Anemia | Phase 2 | Status: COMPLETED | Results posted: 2023-12-11